James Robinson On The Drug Market, Innovation, Biosimilars, and What The French Get Right
Listen now
Description
Health Affairs Editor-in-Chief Alan Weil interviews James Robinson from the University of California, Berkeley School of Public Health on drug innovation, biosimilars, and market competition in the United States and beyond.
More Episodes
Health Affairs Editor-in-Chief Alan Weil interviews Isabel Morgan, director of the the Birth Equity Research Scholars Program at the National Birth Equity Collaborative, on the affects of structural racism on black birthing people's mental health and how we can do better.
Published 10/19/21
Listen to Health Affairs Editor-in-Chief, Alan Weil, interview Jennifer Moore, founding executive director of the Institute for Medicaid Innovation, on perinatal mental health, what we know about it, and what policy option exist to improve it.
Published 10/12/21
Health Affairs Editor-in-Chief Alan Weil interviews Jody Heymann from the University of California, Los Angeles joins A Health Podyssey to talk about access to paid and unpaid sick leave, why the US stands alone globally in having a limited safety net for sick leave — and what it means for...
Published 10/05/21